Detection of alpha-1-antitrypsin PiZ individuals by SSCP and DNA sequencing in formalin-fixed and paraffin-embedded tissue: A comparison with immunohistochemical analysis

Journal of Hepatology

Volumn 32, Issue 3, 2000, Pages 406-411

  Ortiz Pallardó, M Elena ^a   Ko, Yon ^a   Sachinidis, Agapios ^a   Vetter, Hans ^a   Fischer, Hans Peter ^b   Zhou, Hui ^b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Alpha 1 antitrypsin deficiency; DNA sequence analysis; Immunohistochemistry; PiZ variant; SSCP

Indexed keywords

ALPHA 1 ANTITRYPSIN; FORMALDEHYDE; PARAFFIN; PROTEINASE INHIBITOR;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA SEQUENCE; EXON; GENE AMPLIFICATION; GENE MUTATION; HISTOPATHOLOGY; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0034012627     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80390-6     Document Type: Article

References (25)

1. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Org. 75:1997;397-415.
2. Norman MR, Mowat AP, Hutchison DC. Molecular basis, clinical consequences and diagnosis of alpha-1 antitrypsin deficiency. [see comments] Ann Clin Biochem. 34:1997;230-246.
3. Billingsley GD, Walter MA, Hammond GL, Cox DW. Physical mapping of four serpin genes: alpha 1-antitrypsin, alpha 1-antichymotrypsin, corticosteroid-binding globulin, and protein C inhibitor, within a 280-kb region on chromosome 14q32.1. Am J Hum Genet. 52:1993;343-353.
4. Fabbretti G, Sergi C, Consales G, Faa G, Brisigotti M, Romeo G, et al. Genetic variants of alpha-1-antitrypsin (AAT). Liver. 12:1992;296-301.
5. Perlmutter DH. The cellular basis for liver injury in alpha 1-antitrypsin deficiency. Hepatology. 13:1991;172-185.
6. Callea F, Fevery J, Massi G, Lievens C, de Groote J, Desmet VJ. Alpha-1-antitrypsin (AAT) and its stimulation in the liver of PiMZ phenotype individuals. A "recruitment-secretory block" ("R-SB") phenomenon. Liver. 4:1984;325-337.
7. Brantly ML, Paul LD, Miller BH, Falk RT, Wu M, Crystal RG. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis. 138:1988;327-336.
8. Sharp HL, Bridges RA, Krivit W, Freier EF. Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder. J Lab Clin Med. 73:1969;934-939.
9. Berg NO, Eriksson S. Liver disease in adults with alpha-1-antitrypsin deficiency. N Engl J Med. 287:1972;1264-1267.
10. Rabinovitz M, Gavaler JS, Kelly RH, Prieto M, Van Thiel DH. Lack of increase in heterozygous alpha 1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma. Hepatology. 15:1992;407-410.
11. Hodges JR, Millward-Sadler GH, Barbatis C, Wright R. Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. N Engl J Med. 304:1981;557-560.
12. Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med. 314:1986;736-739.
13. Callea F, Fevery J, De Groote J, Desmet VJ. Detection of Pi Z phenotype individuals by alpha-1-antitrypsin (AAT) immunohistochemistry in paraffin-embedded liver tissue specimens. J Hepatol. 2:1986;389-401.
14. Zhou H, Fischer HP. Liver carcinoma in PiZ alpha-1-antitrypsin deficiency. Am J Surg Pathol. 22:1998;742-748.
15. Weirich G, Hornauer MA, Bruning T, Hofler H, Brauch H. Fixed archival tissue. Purify DNA and primers for good PCR yield! Mol Biotechnol. 8:1997;299-301.
16. Bassam BJ, Caetano-Anolles G, Gresshoff PM. Fast and sensitive silver staining of DNA in polyacrylamide gels [published erratum appears in Anal Biochem 1991 Oct; 198(1): 217]. Anal Biochem. 196:1991;80-83.
17. Morse JO. Alpha1-antitrypsin deficiency. (second of two parts) N Engl J Med. 299:1978;1099-1105.
18. Morse JO. Alpha-1-antitrypsin deficiency. (first of two parts) N Engl J Med. 299:1978;1045-1048.
19. Newton CR, Kalsheker N, Graham A, Powell S, Gammack A, Riley J, et al. Diagnosis of alpha 1-antitrypsin deficiency by enzymatic amplification of human genomic DNA and direct sequencing of polymerase chain reaction products. Nucleic Acids Res. 16:1988;8233-8243.
20. Callea F, Brisigotti M, Faa G, Lucini L, Eriksson S. Identification of PiZ gene products in liver tissue by a monoclonal antibody specific for the Z mutant of alpha 1-antitrypsin. J Hepatol. 12:1991;372-376.
21. Dry PJ. Rapid detection of alpha-1-antitrypsin deficiency by analysis of a PCR-induced TaqI restriction site. Hum Genet. 87:1991;742-744.
22. Bruun-Petersen K, Bruun-Petersen G, Dahl R, Larsen B, Kolvraa S, Koch J, et al. Alpha 1-antitrypsin alleles in patients with pulmonary emphysema, detected by DNA amplification (PCR) and oligonucleotide probes. Eur Respir J. 5:1992;531-537.
23. Humphries SE, Gudnason V, Whittall R, Day IN. Single-strand conformation polymorphism analysis with high throughput modifications, and its use in mutation detection in familial hyper-cholesterolemia. International Federation of Clinical Chemistry Scientific Division: Committee on Molecular Biology Techniques. Clin Chem. 43:1997;427-435.
24. Bruning T, Weirich G, Hornauer MA, Hofler H, Brauch H. Renal cell carcinomas in trichloroethene (TRI) exposed persons are associated with somatic mutations in the von Hippel-Lindau (VHL) tumour suppressor gene. Arch Toxicol. 71:1997;332-335.
25. Ben-Ezra J, Johnson DA, Rossi J, Cook N, Wu A. Effect of fixation on the amplification of nucleic acids from paraffin- embedded material by the polymerase chain reaction. J Histochem Cytochem. 39:1991;351-354.